Q4 2019 DexCom Inc Earnings Call

13/2/2020 16:30

Llamada en conferencia DexCom Inc

DexCom Inc Conference call or earnings call will be held on 13-feb-2020
During the earnings conference call’s session, DexCom Inc will provide updated information and financial performance report status.
In order to join the earning call, dial the conference’s bridge and key in the PIN code. Contact DexCom Inc for this information
More and more companies choose to conduct their earnings calls through conference calls and online meetings and it’s important to keep up to date with all relevant information.
Need a conference calls service solution? Try QCONF conferencing today, Sign up now and get 5 free conference calls (no credit card required)
Is this is your first earnings call? Check out Nasdaq guide for how to read an earnings report?
We are a medical device company primarily focused on the design, development and commercialization of continuous glucose monitoring ("CGM") systems for ambulatory use by people with diabetes and by healthcare providers in the hospital for the treatment of people with and without diabetes. Unless the context requires otherwise, the terms "we," "us," "our," the "company," or "DexCom" refer to DexCom, Inc. and its subsidiaries. Products Ambulatory Product Line: SEVEN® PLUS, DexCom G4®, DexCom G4® PLATINUM, DexCom ShareTM System and DexCom G5® Mobile We received approval from the Food and Drug Administration ("FDA") and commercialized our first product in 2006. In 2009 we received approval and began commercializing our third generation system, the DexCom SEVEN PLUS. We no longer market or provide support for the DexCom SEVEN PLUS system.    
Leer más Llamada en conferencia

DexCom Inc (DXCM)

6340 Sequence Drive, San Diego California 92121, United States